Karen Pulford
Oxford, ENG OX39DU, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Epitope mapping of anti-ALK antibodies in children with anaplastic large cell lymphoma.
Journal: Clinical immunology (Orlando, Fla.)
Published: April 30, 2018
Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients.
Journal: Advances in hematology
Published: July 30, 2017
Anti-ALK Antibodies in Patients with ALK-Positive Malignancies Not Expressing NPM-ALK.
Journal: Journal of Cancer
Published: February 10, 2016
Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis.
Journal: PloS one
Published: June 08, 2015
Increased Expression of Phosphorylated FADD in Anaplastic Large Cell and Other T-Cell Lymphomas.
Journal: Biomarker insights
Published: May 04, 2014
Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients.
Journal: Leukemia
Published: May 16, 2013
BCL7A protein expression in normal and malignant lymphoid tissues.
Journal: British journal of haematology
Published: October 10, 2012
Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis.
Journal: Leukemia
Published: August 22, 2012
Last Updated: 09/26/2026